Pharma & Healthcare
Global Veterinary mRNA Vaccines Market Research Report 2025
- Dec 02, 25
- ID: 135871
- Pages: 83
- Figures: 84
- Views: 38
This report aims to provide a comprehensive presentation of the global market for Veterinary mRNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary mRNA Vaccines.
The Veterinary mRNA Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary mRNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, by Company Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary mRNA Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
Ceva Animal Health
Tiba Biotechnology
Jinyu Biotechnology
Harbin Enwei Biological Pharmaceutical
Shanghai Rnacure Biopharma
Ruipu Biotechnology
Jiangsu Synthgene Biotechnology
Genvax Technologies
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Segment by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Segment by Company Type
Vaccine Developers
Drug Manufacturers
Segment by Administration Method
Injectable Drug Administration
Non-invasive Drug Administration
Segment by Application
Pigs
Poultry
Ruminants
Companion Animals
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Company Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary mRNA Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Veterinary mRNA Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary mRNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, by Company Type and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary mRNA Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
Ceva Animal Health
Tiba Biotechnology
Jinyu Biotechnology
Harbin Enwei Biological Pharmaceutical
Shanghai Rnacure Biopharma
Ruipu Biotechnology
Jiangsu Synthgene Biotechnology
Genvax Technologies
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Segment by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Segment by Company Type
Vaccine Developers
Drug Manufacturers
Segment by Administration Method
Injectable Drug Administration
Non-invasive Drug Administration
Segment by Application
Pigs
Poultry
Ruminants
Companion Animals
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Company Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary mRNA Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-replicating mRNA Vaccine
1.2.3 Self-amplifying mRNA Vaccine
1.3 Market by Company Type
1.3.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Company Type: 2020 VS 2024 VS 2031
1.3.2 Vaccine Developers
1.3.3 Drug Manufacturers
1.4 Market by Administration Method
1.4.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Administration Method: 2020 VS 2024 VS 2031
1.4.2 Injectable Drug Administration
1.4.3 Non-invasive Drug Administration
1.5 Market by Application
1.5.1 Global Veterinary mRNA Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Pigs
1.5.3 Poultry
1.5.4 Ruminants
1.5.5 Companion Animals
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Veterinary mRNA Vaccines Market Perspective (2020-2031)
2.2 Global Veterinary mRNA Vaccines Growth Trends by Region
2.2.1 Global Veterinary mRNA Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Veterinary mRNA Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Veterinary mRNA Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Veterinary mRNA Vaccines Market Dynamics
2.3.1 Veterinary mRNA Vaccines Industry Trends
2.3.2 Veterinary mRNA Vaccines Market Drivers
2.3.3 Veterinary mRNA Vaccines Market Challenges
2.3.4 Veterinary mRNA Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary mRNA Vaccines Players by Revenue
3.1.1 Global Top Veterinary mRNA Vaccines Players by Revenue (2020-2025)
3.1.2 Global Veterinary mRNA Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Top Veterinary mRNA Vaccines Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Veterinary mRNA Vaccines Revenue
3.4 Global Veterinary mRNA Vaccines Market Concentration Ratio
3.4.1 Global Veterinary mRNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary mRNA Vaccines Revenue in 2024
3.5 Global Key Players of Veterinary mRNA Vaccines Head office and Area Served
3.6 Global Key Players of Veterinary mRNA Vaccines, Product and Application
3.7 Global Key Players of Veterinary mRNA Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary mRNA Vaccines Breakdown Data by Type
4.1 Global Veterinary mRNA Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Veterinary mRNA Vaccines Forecasted Market Size by Type (2026-2031)
5 Veterinary mRNA Vaccines Breakdown Data by Application
5.1 Global Veterinary mRNA Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Veterinary mRNA Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Veterinary mRNA Vaccines Market Size (2020-2031)
6.2 North America Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Veterinary mRNA Vaccines Market Size by Country (2020-2025)
6.4 North America Veterinary mRNA Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary mRNA Vaccines Market Size (2020-2031)
7.2 Europe Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Veterinary mRNA Vaccines Market Size by Country (2020-2025)
7.4 Europe Veterinary mRNA Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Veterinary mRNA Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Veterinary mRNA Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Veterinary mRNA Vaccines Market Size (2020-2031)
9.2 Latin America Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Veterinary mRNA Vaccines Market Size by Country (2020-2025)
9.4 Latin America Veterinary mRNA Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary mRNA Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Details
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Veterinary mRNA Vaccines Introduction
11.1.4 Merck Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.1.5 Merck Animal Health Recent Development
11.2 Ceva Animal Health
11.2.1 Ceva Animal Health Company Details
11.2.2 Ceva Animal Health Business Overview
11.2.3 Ceva Animal Health Veterinary mRNA Vaccines Introduction
11.2.4 Ceva Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.2.5 Ceva Animal Health Recent Development
11.3 Tiba Biotechnology
11.3.1 Tiba Biotechnology Company Details
11.3.2 Tiba Biotechnology Business Overview
11.3.3 Tiba Biotechnology Veterinary mRNA Vaccines Introduction
11.3.4 Tiba Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.3.5 Tiba Biotechnology Recent Development
11.4 Jinyu Biotechnology
11.4.1 Jinyu Biotechnology Company Details
11.4.2 Jinyu Biotechnology Business Overview
11.4.3 Jinyu Biotechnology Veterinary mRNA Vaccines Introduction
11.4.4 Jinyu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.4.5 Jinyu Biotechnology Recent Development
11.5 Harbin Enwei Biological Pharmaceutical
11.5.1 Harbin Enwei Biological Pharmaceutical Company Details
11.5.2 Harbin Enwei Biological Pharmaceutical Business Overview
11.5.3 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Introduction
11.5.4 Harbin Enwei Biological Pharmaceutical Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.5.5 Harbin Enwei Biological Pharmaceutical Recent Development
11.6 Shanghai Rnacure Biopharma
11.6.1 Shanghai Rnacure Biopharma Company Details
11.6.2 Shanghai Rnacure Biopharma Business Overview
11.6.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Introduction
11.6.4 Shanghai Rnacure Biopharma Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.6.5 Shanghai Rnacure Biopharma Recent Development
11.7 Ruipu Biotechnology
11.7.1 Ruipu Biotechnology Company Details
11.7.2 Ruipu Biotechnology Business Overview
11.7.3 Ruipu Biotechnology Veterinary mRNA Vaccines Introduction
11.7.4 Ruipu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.7.5 Ruipu Biotechnology Recent Development
11.8 Jiangsu Synthgene Biotechnology
11.8.1 Jiangsu Synthgene Biotechnology Company Details
11.8.2 Jiangsu Synthgene Biotechnology Business Overview
11.8.3 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Introduction
11.8.4 Jiangsu Synthgene Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.8.5 Jiangsu Synthgene Biotechnology Recent Development
11.9 Genvax Technologies
11.9.1 Genvax Technologies Company Details
11.9.2 Genvax Technologies Business Overview
11.9.3 Genvax Technologies Veterinary mRNA Vaccines Introduction
11.9.4 Genvax Technologies Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.9.5 Genvax Technologies Recent Development
11.10 Shanghai Shen Lian Biomedical
11.10.1 Shanghai Shen Lian Biomedical Company Details
11.10.2 Shanghai Shen Lian Biomedical Business Overview
11.10.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Introduction
11.10.4 Shanghai Shen Lian Biomedical Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.10.5 Shanghai Shen Lian Biomedical Recent Development
11.11 Suzhou Kerui Meide Biomedical Technology
11.11.1 Suzhou Kerui Meide Biomedical Technology Company Details
11.11.2 Suzhou Kerui Meide Biomedical Technology Business Overview
11.11.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Introduction
11.11.4 Suzhou Kerui Meide Biomedical Technology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.11.5 Suzhou Kerui Meide Biomedical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-replicating mRNA Vaccine
1.2.3 Self-amplifying mRNA Vaccine
1.3 Market by Company Type
1.3.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Company Type: 2020 VS 2024 VS 2031
1.3.2 Vaccine Developers
1.3.3 Drug Manufacturers
1.4 Market by Administration Method
1.4.1 Global Veterinary mRNA Vaccines Market Size Growth Rate by Administration Method: 2020 VS 2024 VS 2031
1.4.2 Injectable Drug Administration
1.4.3 Non-invasive Drug Administration
1.5 Market by Application
1.5.1 Global Veterinary mRNA Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Pigs
1.5.3 Poultry
1.5.4 Ruminants
1.5.5 Companion Animals
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Veterinary mRNA Vaccines Market Perspective (2020-2031)
2.2 Global Veterinary mRNA Vaccines Growth Trends by Region
2.2.1 Global Veterinary mRNA Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Veterinary mRNA Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Veterinary mRNA Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Veterinary mRNA Vaccines Market Dynamics
2.3.1 Veterinary mRNA Vaccines Industry Trends
2.3.2 Veterinary mRNA Vaccines Market Drivers
2.3.3 Veterinary mRNA Vaccines Market Challenges
2.3.4 Veterinary mRNA Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary mRNA Vaccines Players by Revenue
3.1.1 Global Top Veterinary mRNA Vaccines Players by Revenue (2020-2025)
3.1.2 Global Veterinary mRNA Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Top Veterinary mRNA Vaccines Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Veterinary mRNA Vaccines Revenue
3.4 Global Veterinary mRNA Vaccines Market Concentration Ratio
3.4.1 Global Veterinary mRNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary mRNA Vaccines Revenue in 2024
3.5 Global Key Players of Veterinary mRNA Vaccines Head office and Area Served
3.6 Global Key Players of Veterinary mRNA Vaccines, Product and Application
3.7 Global Key Players of Veterinary mRNA Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary mRNA Vaccines Breakdown Data by Type
4.1 Global Veterinary mRNA Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Veterinary mRNA Vaccines Forecasted Market Size by Type (2026-2031)
5 Veterinary mRNA Vaccines Breakdown Data by Application
5.1 Global Veterinary mRNA Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Veterinary mRNA Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Veterinary mRNA Vaccines Market Size (2020-2031)
6.2 North America Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Veterinary mRNA Vaccines Market Size by Country (2020-2025)
6.4 North America Veterinary mRNA Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary mRNA Vaccines Market Size (2020-2031)
7.2 Europe Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Veterinary mRNA Vaccines Market Size by Country (2020-2025)
7.4 Europe Veterinary mRNA Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Veterinary mRNA Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Veterinary mRNA Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Veterinary mRNA Vaccines Market Size (2020-2031)
9.2 Latin America Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Veterinary mRNA Vaccines Market Size by Country (2020-2025)
9.4 Latin America Veterinary mRNA Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary mRNA Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Veterinary mRNA Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Details
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Veterinary mRNA Vaccines Introduction
11.1.4 Merck Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.1.5 Merck Animal Health Recent Development
11.2 Ceva Animal Health
11.2.1 Ceva Animal Health Company Details
11.2.2 Ceva Animal Health Business Overview
11.2.3 Ceva Animal Health Veterinary mRNA Vaccines Introduction
11.2.4 Ceva Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.2.5 Ceva Animal Health Recent Development
11.3 Tiba Biotechnology
11.3.1 Tiba Biotechnology Company Details
11.3.2 Tiba Biotechnology Business Overview
11.3.3 Tiba Biotechnology Veterinary mRNA Vaccines Introduction
11.3.4 Tiba Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.3.5 Tiba Biotechnology Recent Development
11.4 Jinyu Biotechnology
11.4.1 Jinyu Biotechnology Company Details
11.4.2 Jinyu Biotechnology Business Overview
11.4.3 Jinyu Biotechnology Veterinary mRNA Vaccines Introduction
11.4.4 Jinyu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.4.5 Jinyu Biotechnology Recent Development
11.5 Harbin Enwei Biological Pharmaceutical
11.5.1 Harbin Enwei Biological Pharmaceutical Company Details
11.5.2 Harbin Enwei Biological Pharmaceutical Business Overview
11.5.3 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Introduction
11.5.4 Harbin Enwei Biological Pharmaceutical Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.5.5 Harbin Enwei Biological Pharmaceutical Recent Development
11.6 Shanghai Rnacure Biopharma
11.6.1 Shanghai Rnacure Biopharma Company Details
11.6.2 Shanghai Rnacure Biopharma Business Overview
11.6.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Introduction
11.6.4 Shanghai Rnacure Biopharma Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.6.5 Shanghai Rnacure Biopharma Recent Development
11.7 Ruipu Biotechnology
11.7.1 Ruipu Biotechnology Company Details
11.7.2 Ruipu Biotechnology Business Overview
11.7.3 Ruipu Biotechnology Veterinary mRNA Vaccines Introduction
11.7.4 Ruipu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.7.5 Ruipu Biotechnology Recent Development
11.8 Jiangsu Synthgene Biotechnology
11.8.1 Jiangsu Synthgene Biotechnology Company Details
11.8.2 Jiangsu Synthgene Biotechnology Business Overview
11.8.3 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Introduction
11.8.4 Jiangsu Synthgene Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.8.5 Jiangsu Synthgene Biotechnology Recent Development
11.9 Genvax Technologies
11.9.1 Genvax Technologies Company Details
11.9.2 Genvax Technologies Business Overview
11.9.3 Genvax Technologies Veterinary mRNA Vaccines Introduction
11.9.4 Genvax Technologies Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.9.5 Genvax Technologies Recent Development
11.10 Shanghai Shen Lian Biomedical
11.10.1 Shanghai Shen Lian Biomedical Company Details
11.10.2 Shanghai Shen Lian Biomedical Business Overview
11.10.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Introduction
11.10.4 Shanghai Shen Lian Biomedical Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.10.5 Shanghai Shen Lian Biomedical Recent Development
11.11 Suzhou Kerui Meide Biomedical Technology
11.11.1 Suzhou Kerui Meide Biomedical Technology Company Details
11.11.2 Suzhou Kerui Meide Biomedical Technology Business Overview
11.11.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Introduction
11.11.4 Suzhou Kerui Meide Biomedical Technology Revenue in Veterinary mRNA Vaccines Business (2020-2025)
11.11.5 Suzhou Kerui Meide Biomedical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Veterinary mRNA Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-replicating mRNA Vaccine
Table 3. Key Players of Self-amplifying mRNA Vaccine
Table 4. Global Veterinary mRNA Vaccines Market Size Growth Rate by Company Type (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Vaccine Developers
Table 6. Key Players of Drug Manufacturers
Table 7. Global Veterinary mRNA Vaccines Market Size Growth Rate by Administration Method (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Injectable Drug Administration
Table 9. Key Players of Non-invasive Drug Administration
Table 10. Global Veterinary mRNA Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Veterinary mRNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 12. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 13. Global Veterinary mRNA Vaccines Market Share by Region (2020-2025)
Table 14. Global Veterinary mRNA Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 15. Global Veterinary mRNA Vaccines Market Share by Region (2026-2031)
Table 16. Veterinary mRNA Vaccines Market Trends
Table 17. Veterinary mRNA Vaccines Market Drivers
Table 18. Veterinary mRNA Vaccines Market Challenges
Table 19. Veterinary mRNA Vaccines Market Restraints
Table 20. Global Veterinary mRNA Vaccines Revenue by Players (2020-2025) & (US$ Million)
Table 21. Global Veterinary mRNA Vaccines Market Share by Players (2020-2025)
Table 22. Global Top Veterinary mRNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary mRNA Vaccines as of 2024)
Table 23. Ranking of Global Top Veterinary mRNA Vaccines Companies by Revenue (US$ Million) in 2024
Table 24. Global 5 Largest Players Market Share by Veterinary mRNA Vaccines Revenue (CR5 and HHI) & (2020-2025)
Table 25. Global Key Players of Veterinary mRNA Vaccines, Headquarters and Area Served
Table 26. Global Key Players of Veterinary mRNA Vaccines, Product and Application
Table 27. Global Key Players of Veterinary mRNA Vaccines, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Veterinary mRNA Vaccines Market Size by Type (2020-2025) & (US$ Million)
Table 30. Global Veterinary mRNA Vaccines Revenue Market Share by Type (2020-2025)
Table 31. Global Veterinary mRNA Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 32. Global Veterinary mRNA Vaccines Revenue Market Share by Type (2026-2031)
Table 33. Global Veterinary mRNA Vaccines Market Size by Application (2020-2025) & (US$ Million)
Table 34. Global Veterinary mRNA Vaccines Revenue Market Share by Application (2020-2025)
Table 35. Global Veterinary mRNA Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 36. Global Veterinary mRNA Vaccines Revenue Market Share by Application (2026-2031)
Table 37. North America Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. North America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 39. North America Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 40. Europe Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Europe Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 42. Europe Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 43. Asia-Pacific Veterinary mRNA Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 44. Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 45. Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2026-2031) & (US$ Million)
Table 46. Latin America Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Latin America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 48. Latin America Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 49. Middle East & Africa Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 50. Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 51. Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 52. Merck Animal Health Company Details
Table 53. Merck Animal Health Business Overview
Table 54. Merck Animal Health Veterinary mRNA Vaccines Product
Table 55. Merck Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 56. Merck Animal Health Recent Development
Table 57. Ceva Animal Health Company Details
Table 58. Ceva Animal Health Business Overview
Table 59. Ceva Animal Health Veterinary mRNA Vaccines Product
Table 60. Ceva Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 61. Ceva Animal Health Recent Development
Table 62. Tiba Biotechnology Company Details
Table 63. Tiba Biotechnology Business Overview
Table 64. Tiba Biotechnology Veterinary mRNA Vaccines Product
Table 65. Tiba Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 66. Tiba Biotechnology Recent Development
Table 67. Jinyu Biotechnology Company Details
Table 68. Jinyu Biotechnology Business Overview
Table 69. Jinyu Biotechnology Veterinary mRNA Vaccines Product
Table 70. Jinyu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 71. Jinyu Biotechnology Recent Development
Table 72. Harbin Enwei Biological Pharmaceutical Company Details
Table 73. Harbin Enwei Biological Pharmaceutical Business Overview
Table 74. Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product
Table 75. Harbin Enwei Biological Pharmaceutical Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 76. Harbin Enwei Biological Pharmaceutical Recent Development
Table 77. Shanghai Rnacure Biopharma Company Details
Table 78. Shanghai Rnacure Biopharma Business Overview
Table 79. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product
Table 80. Shanghai Rnacure Biopharma Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 81. Shanghai Rnacure Biopharma Recent Development
Table 82. Ruipu Biotechnology Company Details
Table 83. Ruipu Biotechnology Business Overview
Table 84. Ruipu Biotechnology Veterinary mRNA Vaccines Product
Table 85. Ruipu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 86. Ruipu Biotechnology Recent Development
Table 87. Jiangsu Synthgene Biotechnology Company Details
Table 88. Jiangsu Synthgene Biotechnology Business Overview
Table 89. Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product
Table 90. Jiangsu Synthgene Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 91. Jiangsu Synthgene Biotechnology Recent Development
Table 92. Genvax Technologies Company Details
Table 93. Genvax Technologies Business Overview
Table 94. Genvax Technologies Veterinary mRNA Vaccines Product
Table 95. Genvax Technologies Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 96. Genvax Technologies Recent Development
Table 97. Shanghai Shen Lian Biomedical Company Details
Table 98. Shanghai Shen Lian Biomedical Business Overview
Table 99. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product
Table 100. Shanghai Shen Lian Biomedical Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 101. Shanghai Shen Lian Biomedical Recent Development
Table 102. Suzhou Kerui Meide Biomedical Technology Company Details
Table 103. Suzhou Kerui Meide Biomedical Technology Business Overview
Table 104. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product
Table 105. Suzhou Kerui Meide Biomedical Technology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 106. Suzhou Kerui Meide Biomedical Technology Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Veterinary mRNA Vaccines Picture
Figure 2. Global Veterinary mRNA Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Veterinary mRNA Vaccines Market Share by Type: 2024 VS 2031
Figure 4. Non-replicating mRNA Vaccine Features
Figure 5. Self-amplifying mRNA Vaccine Features
Figure 6. Global Veterinary mRNA Vaccines Market Size Comparison by Company Type (2020-2031) & (US$ Million)
Figure 7. Vaccine Developers Features
Figure 8. Drug Manufacturers Features
Figure 9. Global Veterinary mRNA Vaccines Market Size Comparison by Administration Method (2020-2031) & (US$ Million)
Figure 10. Injectable Drug Administration Features
Figure 11. Non-invasive Drug Administration Features
Figure 12. Global Veterinary mRNA Vaccines Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Veterinary mRNA Vaccines Market Share by Application: 2024 VS 2031
Figure 14. Pigs Case Studies
Figure 15. Poultry Case Studies
Figure 16. Ruminants Case Studies
Figure 17. Companion Animals Case Studies
Figure 18. Veterinary mRNA Vaccines Report Years Considered
Figure 19. Global Veterinary mRNA Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Veterinary mRNA Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Veterinary mRNA Vaccines Market Share by Region: 2024 VS 2031
Figure 22. Global Veterinary mRNA Vaccines Market Share by Players in 2024
Figure 23. Global Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. The Top 10 and 5 Players Market Share by Veterinary mRNA Vaccines Revenue in 2024
Figure 25. North America Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 27. United States Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 31. Germany Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Ireland Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Veterinary mRNA Vaccines Market Share by Region (2020-2031)
Figure 39. China Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia & New Zealand Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 47. Mexico Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 51. Israel Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Merck Animal Health Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 55. Ceva Animal Health Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 56. Tiba Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 57. Jinyu Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 58. Harbin Enwei Biological Pharmaceutical Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 59. Shanghai Rnacure Biopharma Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 60. Ruipu Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 61. Jiangsu Synthgene Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 62. Genvax Technologies Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 63. Shanghai Shen Lian Biomedical Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 64. Suzhou Kerui Meide Biomedical Technology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Veterinary mRNA Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-replicating mRNA Vaccine
Table 3. Key Players of Self-amplifying mRNA Vaccine
Table 4. Global Veterinary mRNA Vaccines Market Size Growth Rate by Company Type (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Vaccine Developers
Table 6. Key Players of Drug Manufacturers
Table 7. Global Veterinary mRNA Vaccines Market Size Growth Rate by Administration Method (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of Injectable Drug Administration
Table 9. Key Players of Non-invasive Drug Administration
Table 10. Global Veterinary mRNA Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Veterinary mRNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 12. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 13. Global Veterinary mRNA Vaccines Market Share by Region (2020-2025)
Table 14. Global Veterinary mRNA Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 15. Global Veterinary mRNA Vaccines Market Share by Region (2026-2031)
Table 16. Veterinary mRNA Vaccines Market Trends
Table 17. Veterinary mRNA Vaccines Market Drivers
Table 18. Veterinary mRNA Vaccines Market Challenges
Table 19. Veterinary mRNA Vaccines Market Restraints
Table 20. Global Veterinary mRNA Vaccines Revenue by Players (2020-2025) & (US$ Million)
Table 21. Global Veterinary mRNA Vaccines Market Share by Players (2020-2025)
Table 22. Global Top Veterinary mRNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary mRNA Vaccines as of 2024)
Table 23. Ranking of Global Top Veterinary mRNA Vaccines Companies by Revenue (US$ Million) in 2024
Table 24. Global 5 Largest Players Market Share by Veterinary mRNA Vaccines Revenue (CR5 and HHI) & (2020-2025)
Table 25. Global Key Players of Veterinary mRNA Vaccines, Headquarters and Area Served
Table 26. Global Key Players of Veterinary mRNA Vaccines, Product and Application
Table 27. Global Key Players of Veterinary mRNA Vaccines, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Veterinary mRNA Vaccines Market Size by Type (2020-2025) & (US$ Million)
Table 30. Global Veterinary mRNA Vaccines Revenue Market Share by Type (2020-2025)
Table 31. Global Veterinary mRNA Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 32. Global Veterinary mRNA Vaccines Revenue Market Share by Type (2026-2031)
Table 33. Global Veterinary mRNA Vaccines Market Size by Application (2020-2025) & (US$ Million)
Table 34. Global Veterinary mRNA Vaccines Revenue Market Share by Application (2020-2025)
Table 35. Global Veterinary mRNA Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 36. Global Veterinary mRNA Vaccines Revenue Market Share by Application (2026-2031)
Table 37. North America Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. North America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 39. North America Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 40. Europe Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Europe Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 42. Europe Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 43. Asia-Pacific Veterinary mRNA Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 44. Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 45. Asia-Pacific Veterinary mRNA Vaccines Market Size by Region (2026-2031) & (US$ Million)
Table 46. Latin America Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Latin America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 48. Latin America Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 49. Middle East & Africa Veterinary mRNA Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 50. Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 51. Middle East & Africa Veterinary mRNA Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 52. Merck Animal Health Company Details
Table 53. Merck Animal Health Business Overview
Table 54. Merck Animal Health Veterinary mRNA Vaccines Product
Table 55. Merck Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 56. Merck Animal Health Recent Development
Table 57. Ceva Animal Health Company Details
Table 58. Ceva Animal Health Business Overview
Table 59. Ceva Animal Health Veterinary mRNA Vaccines Product
Table 60. Ceva Animal Health Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 61. Ceva Animal Health Recent Development
Table 62. Tiba Biotechnology Company Details
Table 63. Tiba Biotechnology Business Overview
Table 64. Tiba Biotechnology Veterinary mRNA Vaccines Product
Table 65. Tiba Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 66. Tiba Biotechnology Recent Development
Table 67. Jinyu Biotechnology Company Details
Table 68. Jinyu Biotechnology Business Overview
Table 69. Jinyu Biotechnology Veterinary mRNA Vaccines Product
Table 70. Jinyu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 71. Jinyu Biotechnology Recent Development
Table 72. Harbin Enwei Biological Pharmaceutical Company Details
Table 73. Harbin Enwei Biological Pharmaceutical Business Overview
Table 74. Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product
Table 75. Harbin Enwei Biological Pharmaceutical Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 76. Harbin Enwei Biological Pharmaceutical Recent Development
Table 77. Shanghai Rnacure Biopharma Company Details
Table 78. Shanghai Rnacure Biopharma Business Overview
Table 79. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product
Table 80. Shanghai Rnacure Biopharma Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 81. Shanghai Rnacure Biopharma Recent Development
Table 82. Ruipu Biotechnology Company Details
Table 83. Ruipu Biotechnology Business Overview
Table 84. Ruipu Biotechnology Veterinary mRNA Vaccines Product
Table 85. Ruipu Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 86. Ruipu Biotechnology Recent Development
Table 87. Jiangsu Synthgene Biotechnology Company Details
Table 88. Jiangsu Synthgene Biotechnology Business Overview
Table 89. Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product
Table 90. Jiangsu Synthgene Biotechnology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 91. Jiangsu Synthgene Biotechnology Recent Development
Table 92. Genvax Technologies Company Details
Table 93. Genvax Technologies Business Overview
Table 94. Genvax Technologies Veterinary mRNA Vaccines Product
Table 95. Genvax Technologies Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 96. Genvax Technologies Recent Development
Table 97. Shanghai Shen Lian Biomedical Company Details
Table 98. Shanghai Shen Lian Biomedical Business Overview
Table 99. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product
Table 100. Shanghai Shen Lian Biomedical Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 101. Shanghai Shen Lian Biomedical Recent Development
Table 102. Suzhou Kerui Meide Biomedical Technology Company Details
Table 103. Suzhou Kerui Meide Biomedical Technology Business Overview
Table 104. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product
Table 105. Suzhou Kerui Meide Biomedical Technology Revenue in Veterinary mRNA Vaccines Business (2020-2025) & (US$ Million)
Table 106. Suzhou Kerui Meide Biomedical Technology Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Veterinary mRNA Vaccines Picture
Figure 2. Global Veterinary mRNA Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Veterinary mRNA Vaccines Market Share by Type: 2024 VS 2031
Figure 4. Non-replicating mRNA Vaccine Features
Figure 5. Self-amplifying mRNA Vaccine Features
Figure 6. Global Veterinary mRNA Vaccines Market Size Comparison by Company Type (2020-2031) & (US$ Million)
Figure 7. Vaccine Developers Features
Figure 8. Drug Manufacturers Features
Figure 9. Global Veterinary mRNA Vaccines Market Size Comparison by Administration Method (2020-2031) & (US$ Million)
Figure 10. Injectable Drug Administration Features
Figure 11. Non-invasive Drug Administration Features
Figure 12. Global Veterinary mRNA Vaccines Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Veterinary mRNA Vaccines Market Share by Application: 2024 VS 2031
Figure 14. Pigs Case Studies
Figure 15. Poultry Case Studies
Figure 16. Ruminants Case Studies
Figure 17. Companion Animals Case Studies
Figure 18. Veterinary mRNA Vaccines Report Years Considered
Figure 19. Global Veterinary mRNA Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Veterinary mRNA Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Veterinary mRNA Vaccines Market Share by Region: 2024 VS 2031
Figure 22. Global Veterinary mRNA Vaccines Market Share by Players in 2024
Figure 23. Global Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. The Top 10 and 5 Players Market Share by Veterinary mRNA Vaccines Revenue in 2024
Figure 25. North America Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 27. United States Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 31. Germany Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Ireland Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Veterinary mRNA Vaccines Market Share by Region (2020-2031)
Figure 39. China Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia & New Zealand Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 47. Mexico Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Veterinary mRNA Vaccines Market Share by Country (2020-2031)
Figure 51. Israel Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Veterinary mRNA Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Merck Animal Health Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 55. Ceva Animal Health Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 56. Tiba Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 57. Jinyu Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 58. Harbin Enwei Biological Pharmaceutical Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 59. Shanghai Rnacure Biopharma Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 60. Ruipu Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 61. Jiangsu Synthgene Biotechnology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 62. Genvax Technologies Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 63. Shanghai Shen Lian Biomedical Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 64. Suzhou Kerui Meide Biomedical Technology Revenue Growth Rate in Veterinary mRNA Vaccines Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232